Marlene & Stewart Greenebaum Cancer Center

0:00

The University of Maryland Marlene and Stewart Greenebaum Cancer Center has been selected as a National Cancer Institute (NCI)-designated cancer center, a distinction shared by only 63 other centers across the country.

In this video, Dr. Kevin Cullen, Cancer Center director, discusses the NCI designation and what it means for the Cancer Center and for our patients.

The NCI bestows this special designation on the nations top cancer centers in recognition of their scientific excellence and outstanding patient care. NCI-designated centers are selected through a highly competitive, peer-reviewed process, made even more competitive in the wake of recent NCI funding cutbacks.

The University of Maryland Greenebaum Cancer Center, located in Baltimore, is part of both the University of Maryland Medical Center and the University of Maryland School of Medicine. All of the centers researchers and physicians are on the faculty of the medical school and other professional schools at the University of Maryland, Baltimore.

Related Links:

The Marlene and Stewart

0:00
Team Xplore's picture
1584 views

About the Video:
Cancer is the second-leading cause of death in this country, closely following heart disease. Although it remains a serious problem, there is some promising research surrounding it underway.

In part one of this two-part interview, our cancer expert Dr. Kevin Cullen discusses some advances in cancer research and treatment, including new methods of targeted cancer therapies and vaccines. Some of the specific topics addressed in this portion of the interview include:

Different types of cancer
Common cancers in men and women
Decline in cancer mortality
Importance of early detection
Treatment advances - new drugs
Growth factor receptors
National Cancer Institute Designation
Minority participation in clinical trials
Health disparities

About the Expert:
Dr. Kevin Cullen is the director of the University of Maryland Marlene and Stewart Greenebaum Cancer Center, located in the University of Maryland Medical Center. He is also a professor of medicine and head of the Program in Oncology at

0:00
Team Xplore's picture
1684 views

About the Video:
Cancer is the second-leading cause of death in this country, closely following heart disease. Although it remains a serious problem, there is some promising research surrounding it underway.

In part two of this two-part interview with Ellen Beth Levitt, our cancer expert Dr. Kevin Cullen discusses advances in cancer research and treatment, including new methods of targeted cancer therapies and vaccines. Some of the specific issues addressed in this portion of the interview include:

New targeted cancer therapies
Treatments with fewer side effects
Genetics and cancer
Effects of smoking, stress or radiation
Personalized medicine and cancer
Cancer vaccines Cancer and HIV

About the Expert:
Dr. Kevin Cullen is the director of the University of Maryland Marlene and Stewart Greenebaum Cancer Center, located at the University of Maryland Medical Center. He is also a professor of medicine and head of the Program in Oncology at the University of Maryland School of Medicine.

Related Links:

3:11

Interview with Dr. Rapoport, who discusses cancer, and cancer treatments at UMGCC

4:34
Team Xplore's picture
1483 views

Nearly 400 cancer survivors, their family members, and Greenebaum Cancer Center staff gathered on Sunday, June 24, 2012, for the University of Maryland Greenebaum Cancer Center's annual Day of Honor celebration at the Hippodrome Theatre in Baltimore. See highlights of the event, which had an Olympics-inspired theme and featured remarks by a cancer center physician, a nurse, and a family member of a cancer patient. Related Links: Information for Patients http://www.umgcc.org/patient_info/index.htm Why Choose UMGCC? http://www.umgcc.org/about_us/why_gcc.htm Ask the Expert http://www.umgcc.org/patient_info/ask_the_expert.htm Cancer Treatment Programs http://www.umgcc.org/treatment/index.htm

0:34

This 33-second commerical focuses on the University of Maryland Greenebaum Cancer Center and its mission to save lives.

Related Links:

About UMGCC
http://www.umgcc.org/about_us/index.htm

Why Choose UMGCC?
http://www.umgcc.org/about_us/why_gcc.htm

Cancer Overviews
http://www.umgcc.org/overview/index.htm

Physicians and Staff
http://www.umgcc.org/physicians/index.htm

0:00

Actress Angelina Jolie stunned many people when she announced that she had a double mastectomy because she carries a gene putting her at high risk for breast cancer. In this interview, two experts from the University of Maryland Greenebaum Cancer Center join us to talk about the genetics of cancer, including who should be tested and the risks/benefits of surgery. Related Links: Cancer Center http://www.umgcc.org/ Treatment Services http://www.umgcc.org/treatment/index.htm Research Programs http://www.umgcc.org/research/ Patient Success Stories http://www.umgcc.org/success/index.htm

0:00

Researchers in the Department of Radiation Oncology at the University of Maryland Marlene and Stewart Greenebaum Cancer Center were instrumental in testing a new image-guided radiotherapy system, known as TrueBeam, that can deliver radiation treatments to cancer patients with sub-millimeter accuracy and in some cases up to 50 percent faster than earlier systems. In this video, Navesh Sharma, M.D., explains this all-digital technology, which is used to treat cancer of the lung, breast, prostate, head and neck, spine and other types of cancer.

Related Links:

Department of Radiation Oncology
http://www.umgcc.org/radiation_oncology_program/

Radiation Oncology Faculty and Staff
http://www.umgcc.org/radiation_oncology_program/doctors.htm

Radiation Oncology Research Laboratory
http://www.umgcc.org/radiation_oncology_program/rorl.htm

Advertisement